Our Alliance Strategy Developing alliances has been one of Genentech's key strategies for success from its inception. Several marketed products and products in clinical development have arisen from successful collaborations. Genentech considers collaborations wherever there is excellent science and the potential for a good strategic fit. Genentech is dedicated to bringing considerable resources to the alliance, and is open to different collaboration structures. Genentech has the resources of a large company, including world-class research, clinical, and sales and marketing expertise, but has retained the energy and drive of a small, growing company.

We welcome opportunities to collaborate on discoveries in the following areas, at any stage of development:

GenenFUND For companies with compelling early-stage technologies or drug candidates, please inquire about GenenFUND, our venture capital fund that makes Series A equity investments.

To Contact Genentech's Business Development Department To best expedite discussions, Genentech recommends that potential collaborators provide a detailed non-confidential package describing the opportunity, including scientific supporting data (such as mechanism of action for therapeutics). The more data that a potential collaborator is able to provide in an initial proposal, the better Genentech can evaluate the potential fit.

Please forward proposals to:

Project Coordinator
Business Development Department
Genentech, Inc.
1 DNA Way, MS 53
South San Francisco, California 94080
Fax (650) 225-3009

Or by email:
businessdevelopment@gene.com